These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 2927555)
1. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ; Stuyt PM; Stalenhoef AF Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555 [TBL] [Abstract][Full Text] [Related]
2. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995 [TBL] [Abstract][Full Text] [Related]
3. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia. O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801 [TBL] [Abstract][Full Text] [Related]
4. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
5. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin]. Brocard JJ; Keller U; Oberhänsli A; Riesen WF Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study]. Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557 [TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease. French JK; White HD; Greaves SC N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688 [TBL] [Abstract][Full Text] [Related]
10. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. Geisel J; Oette K; Burrichter H Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032 [TBL] [Abstract][Full Text] [Related]
11. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606 [TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. Maher VM; Thompson GR Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917 [TBL] [Abstract][Full Text] [Related]
13. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus]. van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia]. Darioli R; Bovet P; Brunner HR; Bercher L Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221 [TBL] [Abstract][Full Text] [Related]
18. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]
19. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363 [TBL] [Abstract][Full Text] [Related]
20. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. Darling GM; Johns JA; McCloud PI; Davis SR N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]